Tabuenca Del Barrio, L.; Nova-Camacho, L.M.; Zubicoa Enériz, A.; Martínez de Espronceda Ezquerro, I.; Córdoba Iturriagagoitia, A.; Borque Rodríguez-Maimón, E.; García-Layana, A.
Prognostic Factor Utility of BAP1 Immunohistochemistry in Uveal Melanoma: A Single Center Study in Spain. Cancers 2021, 13, 5347.
https://doi.org/10.3390/cancers13215347
AMA Style
Tabuenca Del Barrio L, Nova-Camacho LM, Zubicoa Enériz A, Martínez de Espronceda Ezquerro I, Córdoba Iturriagagoitia A, Borque Rodríguez-Maimón E, García-Layana A.
Prognostic Factor Utility of BAP1 Immunohistochemistry in Uveal Melanoma: A Single Center Study in Spain. Cancers. 2021; 13(21):5347.
https://doi.org/10.3390/cancers13215347
Chicago/Turabian Style
Tabuenca Del Barrio, Laura, Luiz Miguel Nova-Camacho, Alicia Zubicoa Enériz, Iñigo Martínez de Espronceda Ezquerro, Alicia Córdoba Iturriagagoitia, Enrique Borque Rodríguez-Maimón, and Alfredo García-Layana.
2021. "Prognostic Factor Utility of BAP1 Immunohistochemistry in Uveal Melanoma: A Single Center Study in Spain" Cancers 13, no. 21: 5347.
https://doi.org/10.3390/cancers13215347
APA Style
Tabuenca Del Barrio, L., Nova-Camacho, L. M., Zubicoa Enériz, A., Martínez de Espronceda Ezquerro, I., Córdoba Iturriagagoitia, A., Borque Rodríguez-Maimón, E., & García-Layana, A.
(2021). Prognostic Factor Utility of BAP1 Immunohistochemistry in Uveal Melanoma: A Single Center Study in Spain. Cancers, 13(21), 5347.
https://doi.org/10.3390/cancers13215347